PT - JOURNAL ARTICLE AU - J.L. Wright AU - S.G. Farmer AU - A. Churg TI - A neutrophil elastase inhibitor reduces cigarette smoke-induced remodelling of lung vessels AID - 10.1183/09031936.03.00095703 DP - 2003 Jul 01 TA - European Respiratory Journal PG - 77--81 VI - 22 IP - 1 4099 - http://erj.ersjournals.com/content/22/1/77.short 4100 - http://erj.ersjournals.com/content/22/1/77.full SO - Eur Respir J2003 Jul 01; 22 AB - Cigarette smoking produces pulmonary hypertension (PHT) through unknown mechanisms. In animal models acute smoke exposure induces cell proliferation in the small arteries adjacent to the alveolar ducts, and chronic exposure results in muscularisation of these vessels, with changes related to the development of PHT. Studies indicate that serine-elastase inhibitors can prevent experimental monocrotaline-induced PHT. This study examined whether they could also prevent cigarette smoke-induced pulmonary vascular disease. Guinea-pigs were exposed to cigarette smoke or air for 6 months. Some animals also received ZD0892, an orally active, synthetic, selective, serine-elastase inhibitor. The percentage of muscularised, small, pulmonary arteries was determined by morphometric analysis of histological sections and vascular cell proliferation by proliferating cell nuclear antigen staining. Vascular cell proliferation was markedly increased in the smoke-exposed animals and the percentage of completely muscularised small vessels was increased four-fold. Cell proliferation indices correlated with muscularisation indices. In the animals treated with ZD0892, the number of completely muscularised vessels was reduced by 50% and cell proliferation was reduced by 61%. These data suggest that smoke-induced cell proliferation leads to pulmonary arterial muscularisation. Serine-elastase inhibitors appear to be able to reduce cell proliferation and vascular remodelling. This study was supported by AstraZeneca (Lund, Sweden) research and development and grant MOP42539 from the Canadian Institutes of Health Research.